IRIS
BANDINI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 385
NA - Nord America 325
AS - Asia 65
Continente sconosciuto - Info sul continente non disponibili 2
Totale 777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 322
SE - Svezia 238
IT - Italia 79
DE - Germania 24
CN - Cina 22
FI - Finlandia 19
TR - Turchia 16
HK - Hong Kong 11
IE - Irlanda 9
IN - India 9
PL - Polonia 4
BE - Belgio 3
IR - Iran 3
CA - Canada 2
EU - Europa 2
GB - Regno Unito 2
GR - Grecia 2
LV - Lettonia 2
MY - Malesia 2
SG - Singapore 2
CZ - Repubblica Ceca 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
Totale 777
Salva come PNG Salva come JPEG
Città #
Lawrence 55
Princeton 55
Ashburn 43
New York 41
Milan 32
Shanghai 22
Helsinki 17
Tekirdağ 13
Turin 12
Dublin 9
Brooklyn 8
Hanover 6
Central 5
Pune 5
Genoa 4
Hong Kong 4
Krakow 3
Washington 3
Antwerp 2
Arvada 2
Bari 2
Delhi 2
Detroit 2
Henderson 2
Kiel 2
Lahti 2
Latina 2
Navi Mumbai 2
Palermo 2
Plymouth 2
Polignano a Mare 2
Riga 2
Rome 2
Seattle 2
Seri Kembangan 2
Silver Spring 2
Singapore 2
Andover 1
Athens 1
Barrafranca 1
Borås 1
Brussels 1
Cesena 1
Cosenza 1
Enna 1
Gunzenhausen 1
Kahramanmaraş 1
Kaunas 1
Leawood 1
Los Angeles 1
Osimo 1
Perosa Argentina 1
Prague 1
Presezzo 1
Rho 1
Rozzano 1
Sacramento 1
Sesto San Giovanni 1
Tehran 1
Thessaloniki 1
Warsaw 1
Zanjan 1
Zapopan 1
Totale 401
Salva come PNG Salva come JPEG
Nome #
Development of a novel signature integrating clinical, imaging and epigenetic information to tailor pelvic nodal treatment in prostate cancer 127
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 28
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 26
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 23
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 20
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 19
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 19
A risk calculator predicting recurrence in lymph node metastatic penile cancer 18
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 18
A global approach to improving penile cancer care 17
Development and Validation of a Lookup Table for the Prediction of Metastatic Prostate Cancer According to Prostatic-specific Antigen Value, Clinical Tumor Stage, and Gleason Grade Groups 17
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 17
Author Correction: Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients (Scientific Reports, (2019), 9, 1, (13218), 10.1038/s41598-019-49250-6) 16
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 16
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 16
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 15
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 14
Targetable gene fusions and aberrations in genitourinary oncology 14
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 14
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 13
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 13
Postoperative paralytic ileus after major oncological procedures in the enhanced recovery after surgery era: A population based analysis 13
Effect of external beam radiotherapy on second primary cancer risk after radical prostatectomy 13
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 13
Molecular subtyping and immune-gene signatures identify a subset of early bladder tumors as candidates for single-agent immune-checkpoint inhibition 13
Vacuum physiotherapy after first stage buccal mucosa graft (BMG) urethroplasty in children with proximal hypospadias 12
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 11
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer 11
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 11
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 11
Salvage pelvic lymph node dissection for lymph node recurrent prostate cancer 10
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 10
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 10
Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations 10
Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636–43 10
Re: Malte W. Vetterlein, Jakob Klemm, Philipp Gild, et al. Improving Estimates of Perioperative Morbidity After Radical Cystectomy Using the European Association of Urology Quality Criteria for Standardized Reporting and Introducing the Comprehensive Complication Index. Eur Urol 2020;77:55–65 10
Causal contributors to tissue stiffness and clinical relevance in urology 10
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 9
The effect of race on survival after local therapy in metastatic prostate cancer patients 9
Is it Time to Consider Eliminating Surgery from the Treatment of Locally Advanced Bladder Cancer? 9
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 9
Neoadjuvant chemotherapy for lymph node-positive penile cancer: Current evidence and knowledge 9
Revolutionizing care for rare genitourinary tumours 9
The new era of precision urobiome: RE: “Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study” by Chipollini et al 9
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 8
Survival benefit of local versus no local treatment for metastatic prostate cancer-Impact of baseline PSA and metastatic substages 8
The effect of age on cancer-specific mortality in patients with small renal masses: A population-based analysis 8
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis 8
Prevalence and surgical management of pubic hypertrophy in hypospadias patients: Results from a high-volume surgeon 8
Pembrolizumab and nab-paclitaxel as salvage therapy for platinum-treated, locally advanced or metastatic urothelial carcinoma: interim results of the open-label, single-arm, phase II PEANUT study 8
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm? 8
Molecular Characterization of Residual Bladder Cancer after Neoadjuvant Pembrolizumab 8
Re: Francesco Soria, Marco Moschini, David D'Andrea, et al. Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study. Eur Urol Focus 2020;6:1233–9 8
Incidental Prostate Cancer (cT1a-cT1b) Is a Relevant Clinical and Research Entity and Should Be Fully Discussed in the International Prostate Cancer Guidelines 8
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration 8
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 7
Nomograms in urologic oncology, advantages and disadvantages 7
Survival Effect of Chemotherapy in Metastatic Upper Urinary Tract Urothelial Carcinoma 7
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC) 7
Prognostic Role of Early Interim Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced Seminoma Undergoing Standard Treatment 5
Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited 5
null 1
null 1
null 1
null 1
null 1
Totale 852
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.696
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.696
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 0 0 0 0 1 0 0 0 2 2 0 0
2020/202132 0 0 0 0 0 25 7 0 0 0 0 0
2021/202296 0 16 3 32 1 0 2 6 2 4 0 30
2022/2023413 131 99 31 11 3 42 11 46 8 3 13 15
2023/2024302 6 25 38 35 33 67 50 40 4 4 0 0
Totale 852